DermQuest logo

For Healthcare Professionals Only

Editorial Board |  Contact Us |  Sitemap |  Log in |  Register |  Help
 
The art, science and practice of dermatology

Forgotten login details?
Register

The latest from Dermquest

Clinical Updates

Head Lice: Epidermiology and Resistence to Pediculicides

13 August 2008

Michel Develoux MD
Pediculosis capitis is a common ectoparasitosis worldwide. Resistance to treatment reflects the wide use of chemical pediculides in several countries with therapeutic pressure against lice. In this article, Dr. Michel Develoux takes an in-depth look at the increasing resistance of P. capitis to pediculicides.

Surgery & Cosmetics

Neurotoxins: Present and Future

13 August 2008

Joel L. Cohen, MD
Several clinical botulinum toxins in development will likely be available in the US in the coming years. In this article, Dr. Joel Cohen discusses the therapeutic uses of Botox and Myobloc/Neurobloc, and highlights several other botulinum toxins on the therapeutic and cosmetic horizon, including Dysport/Reloxin, Xeomin, Prosigne, and PurTox.

News Headlines

Long-term tacrolimus treatment well tolerated in atopic dermatitis

15 August 2008

Tacrolimus is well tolerated and has sustained efficacy when used for up to 4 years in patients with atopic dermatitis, according to the results of a long-term study.

PKC inhibitor AEB071 shows psoriasis treatment potential

15 August 2008

The novel protein kinase C inhibitor AEB071 significantly reduces the clinical severity of psoriasis and may be an effective treatment for the condition and other autoimmune diseases, say researchers.

Digital photography effective for patient counseling and education

15 August 2008

Digital imaging can be a valuable tool for the dermatologist for patient counseling and follow-up, study findings suggest.